BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31771307)

  • 1. Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.
    Puente A; Fortea JI; Del Pozo C; Huelin P; Cagigal ML; Serrano M; Cabezas J; Arias Loste MT; Iruzubieta P; Cuadrado A; Llerena S; Lopez C; Fábrega E; Crespo J
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites.
    Yazaki T; Kawashima K; Ishimura N; Kataoka M; Fukunaga M; Hyakudomi R; Tajima Y; Moriyama I; Araki A; Kadota K; Shibagaki K; Tobita H; Ishihara S
    Intern Med; 2022 Nov; 61(21):3225-3231. PubMed ID: 35370236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer.
    Huang X; Li F; Wang L; Xiao M; Ni L; Jiang S; Ji Y; Zhang C; Zhang W; Wang J; Chen S
    Endoscopy; 2020 Sep; 52(9):727-735. PubMed ID: 32380558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic variceal bleeding secondary to porto-sinusoidal vascular disease.
    Antón RodrÍguez Á; Puente Sánchez ÁM; Fortea JI; Odriozola Herrán A; Echavarría Rodríguez VJ; Alonso Fernández S; Montano Lumbreras E
    Rev Esp Enferm Dig; 2024 May; 116(5):287-288. PubMed ID: 37314140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated gastric variceal bleeding related to non-cirrhotic portal hypertension following oxaliplatin-based chemotherapy: A case report.
    Zhang X; Gao YY; Song DZ; Qian BX
    World J Gastroenterol; 2022 Jul; 28(27):3524-3531. PubMed ID: 36158260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury.
    Slade JH; Alattar ML; Fogelman DR; Overman MJ; Agarwal A; Maru DM; Coulson RL; Charnsangavej C; Vauthey JN; Wolff RA; Kopetz S
    Clin Colorectal Cancer; 2009 Oct; 8(4):225-30. PubMed ID: 19822514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.
    Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-cirrhotic portal hypertension - The point of view of the pathologis].
    Blank A; Terracciano L
    Ther Umsch; 2019; 76(7):359-363. PubMed ID: 31913095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of portal hypertension after the treatment of oxaliplatin based adjuvant chemotherapy for rectal cancer].
    Heo J; Shin KY; Kwon YH; Park SY; Jung MK; Cho CM; Tak WY; Kweon YO
    Korean J Gastroenterol; 2011 Apr; 57(4):253-7. PubMed ID: 21519180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
    Madbouly KM; Hussein AM; Zeid A
    Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
    Ryan P; Nanji S; Pollett A; Moore M; Moulton CA; Gallinger S; Guindi M
    Am J Surg Pathol; 2010 Jun; 34(6):784-91. PubMed ID: 20421779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension secondary to non-cirrhotic perisinusoidal hepatic fibrosis.
    Jacobi D; de Muret A; Arbeille B; Perarnau JM
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):549-51. PubMed ID: 16607154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
    Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
    PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cases of rupture of esophagogastric varices during the course of oxaliplatin-based chemotherapy for colorectal cancer].
    Shigefuku R; Takahashi H; Tsuda T; Ikeda H; Matsunaga K; Matsumoto N; Okuse C; Boku N; Itoh F; Suzuki M
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2326-36. PubMed ID: 25482909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case Report of Nodular Regenerative Hyperplasia and Non-cirrhotic Portal Hypertension Post Oxaliplatin Chemotherapy.
    Ganta N; Prasad A; Aknouk M; Ghodasara K; Nair A; Taqvi Z; Cheriyath P
    Cureus; 2022 Sep; 14(9):e28740. PubMed ID: 36211116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.
    Overman MJ; Maru DM; Charnsangavej C; Loyer EM; Wang H; Pathak P; Eng C; Hoff PM; Vauthey JN; Wolff RA; Kopetz S
    J Clin Oncol; 2010 May; 28(15):2549-55. PubMed ID: 20406923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    Jarzabek MA; Proctor WR; Vogt J; Desai R; Dicker P; Cain G; Raja R; Brodbeck J; Stevens D; van der Stok EP; Martens JWM; Verhoef C; Hegde PS; Byrne AT; Tarrant JM
    PLoS One; 2018; 13(6):e0198099. PubMed ID: 29879147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porto-sinusoidal vascular disease: proposal and description of a novel entity.
    De Gottardi A; Rautou PE; Schouten J; Rubbia-Brandt L; Leebeek F; Trebicka J; Murad SD; Vilgrain V; Hernandez-Gea V; Nery F; Plessier A; Berzigotti A; Bioulac-Sage P; Primignani M; Semela D; Elkrief L; Bedossa P; Valla D; Garcia-Pagan JC;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):399-411. PubMed ID: 30957754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary phase liver MR imaging findings after Oxaliplatin-based chemotherapy in cancer patients.
    Ünal E; Karaosmanoğlu AD; Ozmen MN; Akata D; Karcaaltincaba M
    Abdom Radiol (NY); 2018 Sep; 43(9):2321-2328. PubMed ID: 29427046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.